Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Kenvue Inc. Common Stock
(NY:
KVUE
)
15.80
-0.01 (-0.09%)
Streaming Delayed Price
Updated: 9:37 AM EDT, Oct 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kenvue Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Should You Buy Kenvue Stock After Its 30% Plunge?
October 01, 2025
There hasn't been much good news lately for this Johnson & Johnson spinoff.
Via
The Motley Fool
Topics
Government
Lawsuit
Cullen Trims KVUE Stake With $149.5M Share Sale
October 01, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Friday's session: most active stock in the S&P500 index
September 26, 2025
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...
Via
Chartmill
Demystifying Kenvue: Insights From 11 Analyst Reviews
September 26, 2025
Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,...
Via
Benzinga
Kenvue Stock To Face More Headwinds? Trump’s Tylenol Warning Revives Autism Lawsuits, Retail Bulls Stay Unfazed
September 24, 2025
Via
Stocktwits
Topics
Government
Lawsuit
Why Is Kenvue Stock Rising Premarket Today?
September 24, 2025
Via
Stocktwits
Why Is Kenvue Stock Rising Today?
September 23, 2025
Via
Stocktwits
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish
September 22, 2025
Via
Stocktwits
Topics
Government
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...'
September 26, 2025
A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.
Via
Benzinga
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
September 24, 2025
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence...
Via
MarketMinute
Topics
Government
Product Recall
What's going on in today's session: S&P500 movers
September 24, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease
September 22, 2025
Via
Stocktwits
Topics
Government
Wednesday's session: most active stock in the S&P500 index
September 24, 2025
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace...
Via
Chartmill
Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning
September 24, 2025
Kenvue's stock rose 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns sparked by President Trump's comments linking acetaminophen to autism.
Via
Benzinga
Topics
Government
Jon Stewart Roasts Trump Over 'Acetaminophen' Pronunciation: 'We Would Like A Second Opinion'
September 24, 2025
Trump struggles to pronounce acetaminophen while warning pregnant women of its potential link to autism. Jon Stewart mocks his incompetence.
Via
Benzinga
Topics
Government
Nvidia, Plug Power, Micron, Kenvue, Kroger: What Sparked Heavy After-Hours Trading In These 5 Stocks?
September 23, 2025
Micron stock showed a muted reaction to earnings despite the quarterly numbers and guidance exceeding expectations.
Via
Stocktwits
Topics
Artificial Intelligence
Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’
September 23, 2025
Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry.
Via
Stocktwits
Topics
Economy
Government
Lawsuit
These S&P500 stocks are the most active in today's session
September 23, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market...
Via
Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
September 23, 2025
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session.
Via
Chartmill
What's Going On With Kenvue Stock Tuesday?
September 23, 2025
Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with...
Via
Benzinga
Topics
Government
Kenvue On Track To Bounce Back From Record Lows — What’s Driving Stock Higher In Premarket?
September 23, 2025
Many doctors reportedly disagreed with the Trump administration’s Tylenol claims and warned that these unfounded claims would likely impair maternal health.
Via
Stocktwits
Topics
Government
Lawsuit
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade—Kenvue, Micron Tech, Nvidia In Focus
September 23, 2025
U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of major benchmark indices were mixed.
Via
Benzinga
Topics
Stocks
Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism
September 23, 2025
Jim Cramer says Trump creates a "nightmare" for Kenvue after linking Tylenol to autism. Learn why KVUE stock is plunging amid lawsuit fears.
Via
Benzinga
Topics
Government
Lawsuit
Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records
September 23, 2025
Tech did the heavy lifting as Nvidia and Apple dragged indexes over the finish line; gold hit yet another all-time high while oil sagged. The Fed chorus grew louder and more discordant.
Via
Chartmill
Topics
Economy
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check?
September 23, 2025
Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks.
Via
Stocktwits
Topics
Government
Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today
September 22, 2025
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54.
Via
Benzinga
Topics
Stocks
Which S&P500 stocks are moving on Monday?
September 22, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via
Chartmill
Curious about the most active S&P500 stocks in today's session?
September 22, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest...
Via
Chartmill
Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday?
September 22, 2025
Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts.
Via
Benzinga
Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off?
September 22, 2025
Shares of Kenvue Inc (NASDAQ: KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products.
Via
Benzinga
Topics
Government
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.